MicroRNA Market Size, Share & Trends Analysis Report By Products & Services, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objective
  • 1.4.1. Objective 1
  • 1.4.2. Objective2
  • 1.4.3. Objective 3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis:
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables and Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Expanding use of miRNA in drug development & therapeutics
    • 3.2.1.2. Increasing cancer prevalence and need for early-stage diagnostics
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost associated with microRNA kits and other products
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Product & Service Business Analysis

• 4.1. Segment Dashboard
• 4.2. MicroRNA Market: Product & Service Movement Analysis
• 4.3. Product
  • 4.3.1. Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Instruments
    • 4.3.2.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2. By Technology
      • 4.3.2.2.1. Real-Time PCR
        • 4.3.2.2.1.1. Real-Time PCR Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2.2. Microarray
        • 4.3.2.2.2.1. Microarray Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2.3. NGS
        • 4.3.2.2.3.1. NGS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2.4. Others
        • 4.3.2.2.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3. By Workflow
      • 4.3.2.3.1. Isolation & Purification
        • 4.3.2.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3.2. miRNA cDNA Synthesis
        • 4.3.2.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3.3. Profiling, Localization, & Qualification
        • 4.3.2.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3.4. Functional Analysis & Others
        • 4.3.2.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3.5. Others
        • 4.3.2.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Consumables
    • 4.3.3.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.2. By Specimen
      • 4.3.3.2.1. Whole Blood
        • 4.3.3.2.1.1. Whole Blood Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2.2. Serum
        • 4.3.3.2.2.1. Serum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2.3. Plasma
        • 4.3.3.2.3.1. Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2.4. FFPE
        • 4.3.3.2.4.1. FFPE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2.5. Fresh Frozen Tissue
        • 4.3.3.2.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2.6. Others
        • 4.3.3.2.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3.3. By Workflow
      • 4.3.3.3.1. Isolation & Purification
        • 4.3.3.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3.2. miRNA cDNA Synthesis
        • 4.3.3.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3.3. Profiling, Localization, & Qualification
        • 4.3.3.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3.4. Functional Analysis & Others
        • 4.3.3.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3.5. Others
        • 4.3.3.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Services
  • 4.4.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. By Service Type
    • 4.4.2.1. Isolation & Purification
      • 4.4.2.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. miRNA cDNA Synthesis
      • 4.4.2.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. Profiling, Localization, & Qualification
      • 4.4.2.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.4. Functional Analysis
      • 4.4.2.4.1. Functional Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.5. Others
      • 4.4.2.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. By Specimen
    • 4.4.3.1. Whole Blood
      • 4.4.3.1.1. Whole Blood Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Serum
      • 4.4.3.2.1. Serum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Plasma
      • 4.4.3.3.1. Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.4. FFPE
      • 4.4.3.4.1. FFPE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.5. Fresh Frozen Tissue
      • 4.4.3.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.6. Others
      • 4.4.3.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Segment Dashboard
• 5.2. MicroRNA Market: Application Movement Analysis
• 5.3. Cancer
  • 5.3.1. Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Infectious Diseases
  • 5.4.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Immunological Disorder
  • 5.5.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Cardiovascular Disease
  • 5.6.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Neurological Disease
  • 5.7.1. Neurological Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. Segment Dashboard
• 6.2. MicroRNA Market: End Use Movement Analysis
• 6.3. Biotechnology & Pharmaceutical Companies
  • 6.3.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Academic & Government Research Institutes
  • 6.4.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Other End-users
  • 6.5.1. Other End-users Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. MicroRNA Market Share By Region, 2024 & 2033
• 7.2. North America
  • 7.2.1. North America MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Regulatory framework
    • 7.2.2.3. Competitive Scenario
    • 7.2.2.4. U.S. MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Regulatory framework
    • 7.2.3.3. Competitive Scenario
    • 7.2.3.4. Canada MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Regulatory framework
    • 7.2.4.3. Competitive Scenario
    • 7.2.4.4. Mexico MicroRNA Market, 2021 - 2033 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. UK MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Germany MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. France MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Regulatory framework
    • 7.3.5.3. Competitive Scenario
    • 7.3.5.4. Italy MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Regulatory framework
    • 7.3.6.3. Competitive Scenario
    • 7.3.6.4. Spain MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Regulatory framework
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Denmark MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Regulatory framework
    • 7.3.8.3. Competitive Scenario
    • 7.3.8.4. Sweden MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Regulatory framework
    • 7.3.9.3. Competitive Scenario
    • 7.3.9.4. Norway MicroRNA Market, 2021 - 2033 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Japan MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. China MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. India MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Australia MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Thailand MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.4.7. South Korea
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. South Korea MicroRNA Market, 2021 - 2033 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Brazil MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Argentina MicroRNA Market, 2021 - 2033 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. South Africa MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Saudi Arabia MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. UAE MicroRNA Market, 2021 - 2033 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Kuwait MicroRNA Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. QIAGEN
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Horizon Discovery Group plc.
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Merck KGaA
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Takara Bio, Inc.
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. LGC Limited
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. BioGenex
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. GeneCopoeia, Inc.
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. New England Biolabs
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. NanoString Technologies, Inc.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 4 Global MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 5 Global MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 6 Global MicroRNA Market, by Region, 2021 - 2033 (USD Million)
• Table 7 North America MicroRNA Market, by Country, 2021 - 2033 (USD Million)
• Table 8 North America MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 9 North America MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 10 North America MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 11 U.S. MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 12 U.S. MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 13 U.S. MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 14 Canada MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 15 Canada MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 16 Canada MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 17 Mexico MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 18 Mexico MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 19 Mexico MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 20 Europe MicroRNA Market, by Country, 2021 - 2033 (USD Million)
• Table 21 Europe MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 22 Europe MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 23 Europe MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 24 Germany MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 25 Germany MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 26 Germany MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 27 UK MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 28 UK MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 29 UK MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 30 France MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 31 France MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 32 France MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 33 Italy MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 34 Italy MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 35 Italy MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 36 Spain MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 37 Spain MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 38 Spain MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 39 Denmark MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 40 Denmark MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 41 Denmark MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 42 Norway MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 43 Norway MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 44 Norway MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 45 Sweden MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 46 Sweden MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 47 Sweden MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 48 Asia Pacific MicroRNA Market, by Country, 2021 - 2033 (USD Million)
• Table 49 Asia Pacific MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 50 Asia Pacific MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 51 Asia Pacific MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 52 Asia Pacific MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 53 China MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 54 China MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 55 China MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 56 Japan MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 57 Japan MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 58 Japan MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 59 India MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 60 India MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 61 India MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 62 South Korea MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 63 South Korea MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 64 South Korea MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 65 Australia MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 66 Australia MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 67 Australia MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 68 Thailand MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 69 Thailand MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 70 Thailand MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 71 Latin America MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 72 Latin America MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 73 Latin America MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 74 Brazil MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 75 Brazil MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 76 Brazil MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 77 Argentina MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 78 Argentina MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 79 Argentina MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 80 Middle East & Africa MicroRNA Market, by Country, 2021 - 2033 (USD Million)
• Table 81 Middle East & Africa MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 82 Middle East & Africa MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 83 Middle East & Africa MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 84 South Africa MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 85 South Africa MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 86 South Africa MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 87 Saudi Arabia MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 88 Saudi Arabia MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 89 Saudi Arabia MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 90 UAE MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 91 UAE MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 92 UAE MicroRNA Market, End-user, 2021 - 2033 (USD Million)
• Table 93 Kuwait MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
• Table 94 Kuwait MicroRNA Market, by Application, 2021 - 2033 (USD Million)
• Table 95 Kuwait MicroRNA Market, End-user, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 MicroRNA market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 Market trends & outlook
• Fig. 16 PESTEL analysis
• Fig. 17 Porter's five forces analysis
• Fig. 18 MicroRNA market: Product & services outlook & key takeaways
• Fig. 19 MicroRNA market: Product & services movement analysis
• Fig. 20 Products Market, 2021 - 2033 (USD million)
• Fig. 21 MicroRNA market: by product type
• Fig. 22 Instruments Market, 2021 - 2033 (USD million)
• Fig. 23 MicroRNA market: by technology
• Fig. 24 Real Time PCR Market, 2021 - 2033 (USD million)
• Fig. 25 Microarray Market, 2021 - 2033 (USD million)
• Fig. 26 NGS Market, 2021 - 2033 (USD million)
• Fig. 27 Others Market, 2021 - 2033 (USD million)
• Fig. 28 MicroRNA market: by workflow
• Fig. 29 Isolation & Purification Market, 2021 - 2033 (USD million)
• Fig. 30 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
• Fig. 31 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
• Fig. 32 Functional Analysis & Others Market, 2021 - 2033 (USD million)
• Fig. 33 Others Market, 2021 - 2033 (USD million)
• Fig. 34 Consumables Market, 2021 - 2033 (USD million)
• Fig. 35 MicroRNA market: by specimen
• Fig. 36 Whole Blood Market, 2021 - 2033 (USD million)
• Fig. 37 Serum Market, 2021 - 2033 (USD million)
• Fig. 38 Plasma Market, 2021 - 2033 (USD million)
• Fig. 39 FFPE Market, 2021 - 2033 (USD million)
• Fig. 40 Fresh Frozen Tissue Market, 2021 - 2033 (USD million)
• Fig. 41 Others Market, 2021 - 2033 (USD million)
• Fig. 42 MicroRNA market: by workflow
• Fig. 43 Isolation & Purification Market, 2021 - 2033 (USD million)
• Fig. 44 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
• Fig. 45 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
• Fig. 46 Functional Analysis Market, 2021 - 2033 (USD million)
• Fig. 47 Others Market, 2021 - 2033 (USD million)
• Fig. 48 Services Market, 2021 - 2033 (USD million)
• Fig. 49 MicroRNA market: by services type
• Fig. 50 Isolation & Purification Market, 2021 - 2033 (USD million)
• Fig. 51 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
• Fig. 52 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
• Fig. 53 Functional Analysis Market, 2021 - 2033 (USD million)
• Fig. 54 Others Market, 2021 - 2033 (USD million)
• Fig. 55 MicroRNA market: specimen
• Fig. 56 Whole Blood Market, 2021 - 2033 (USD million)
• Fig. 57 Serum Market, 2021 - 2033 (USD million)
• Fig. 58 Plasma Market, 2021 - 2033 (USD million)
• Fig. 59 FFPE Market, 2021 - 2033 (USD million)
• Fig. 60 Fresh Frozen Tissue Market, 2021 - 2033 (USD million)
• Fig. 61 Others Market, 2021 - 2033 (USD million)
• Fig. 62 MicroRNA market: Application outlook key takeaways
• Fig. 63 MicroRNA market: Application movement analysis
• Fig. 64 Cancer Market, 2021 - 2033 (USD million)
• Fig. 65 Infectious Diseases Market, 2021 - 2033 (USD million)
• Fig. 66 Immunological Disorder Market, 2021 - 2033 (USD million)
• Fig. 67 Cardiovascular Disease Market, 2021 - 2033 (USD million)
• Fig. 68 Neurological Disease Market, 2021 - 2033 (USD million)
• Fig. 69 Others Market, 2021 - 2033 (USD million)
• Fig. 70 MicroRNA market: End use outlook key takeaways
• Fig. 71 MicroRNA market: End use movement analysis
• Fig. 72 Biotechnology & Pharmaceutical Companies Market, 2021 - 2033 (USD million)
• Fig. 73 Academic & Government Research Institutes Market, 2021 - 2033 (USD million)
• Fig. 74 Others Market, 2021 - 2033 (USD million)
• Fig. 75 Regional outlook
• Fig. 76 Regional marketplace: Key takeaways
• Fig. 77 North America microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 78 Key country dynamics
• Fig. 79 U S microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 80 Key country dynamics
• Fig. 81 Canada microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 82 Key country dynamics
• Fig. 83 Mexico microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 84 Europe microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 85 Key country dynamics
• Fig. 86 Germany microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 87 Key country dynamics
• Fig. 88 UK microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 89 Key country dynamics
• Fig. 90 France microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 91 Key country dynamics
• Fig. 92 Italy microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 93 Key country dynamics
• Fig. 94 Spain microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 95 Key country dynamics
• Fig. 96 Denmark microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 97 Key country dynamics
• Fig. 98 Sweden microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 99 Key country dynamics
• Fig. 100 Norway microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 101 Asia Pacific microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 102 Key country dynamics
• Fig. 103 Japan microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 104 Key country dynamics
• Fig. 105 China microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 106 Key country dynamics
• Fig. 107 India microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 108 Key country dynamics
• Fig. 109 Australia microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 110 Key country dynamics
• Fig. 111 Thailand microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 112 Key country dynamics
• Fig. 113 South Korea microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 114 Latin America microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 115 Key country dynamics
• Fig. 116 Brazil microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 117 Key country dynamics
• Fig. 118 Argentina microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 119 MEA microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 120 Key country dynamics
• Fig. 121 South Africa microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 122 Key country dynamics
• Fig. 123 Saudi Arabia microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 124 Key country dynamics
• Fig. 125 UAE microRNA market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 126 Key country dynamics
• Fig. 127 Kuwait microRNA market estimates and forecasts, 2021 - 2033 (USD million)